The federal government’s plan to push patented drug prices lower continues to meet with controversy. The changes to the regulations governing the Patented Medicine Prices Review Board (PMPRB) have aroused criticism from
Tag: Access
Four things you should know about the pending Charter challenge against Medicare
By Colleen Flood and Kathleen O’Grady, EvidenceNetwork.ca A version of this commentary appeared in the Globe and Mail, the Medical Post and the Windsor Star A long-running dispute between Dr. Brian Day, the co-owner of Cambie Surgeries
Take part in CCSN’s important survey on Xgeva!
The purpose of this survey is to provide the Canadian Cancer Survivor Network (CCSN) with insights and perspectives about the use of denosumab (Xgeva) for the prevention of skeletal-related events due to
What do cancer patients want?
What do cancer patients want? By Jackie Manthorne Presented at the Economic Club of Canada April 14, 2014 Thank you very much for your kind introduction. And I would also like to
Finding Flexible Work Difficult for Cancer Patients and Caregivers
New data released on financial, decision-making and emotional burden of cancer LAVAL, Quebec, January 14, 2014 – A 2013 Léger national survey of cancer patients and their caregivers, commissioned by Sanofi Canada, sheds
Survey Highlights Ontarians’ Perceptions on Access to Medications in Canada
Only one-fifth believe that if they were diagnosed with cancer today, all their medications would be covered by their province’s healthcare system or medical insurance1 TORONTO, June 14, 2012 /CNW/ – Ontarians